Specifically, cognitive dysfunction, especially Alzheimer's disease (AD), is associated with elevated blood levels of pro-inflammatory markers, such as C-reactive protein and interleukin-6 (e.g., Ravaglia et al., 2007). This evidence concerns the gene IL6 and Alzheimer disease.